Navigation Links
Preparing for bioterrorism
Date:12/12/2012

DECEMBER 12, 2012Baltimore, MD A new book, Preparing for Bioterrorism, written by Gigi Kwik Gronvall and published by the Center for Biosecurity of UPMC, tells the story of some of the important biosecurity projects funded by the Alfred P. Sloan Foundation and how they left the nation better prepared to deal with bioterrorism. Each project is its own story in the book. What emerges is a history of the past decade of progress in biosecurity preparedness in communities across the country and around the world.

Before 9/11 and the anthrax letter attacks, the US government was mostly concerned about biological attacks on the military, on soldiersit was not prepared for attacks on civilians. Few had seriously planned for such a biological threat, and there was certainly no multidisciplinary community devoted to improving biosecurity.

The Alfred P. Sloan Foundation identified this as a critical gap. In 2000 they started funding projects in civilian preparedness and built a network of experts who were working through these problems. Before biosecurity even existed as a professional field, they were in a good position to put their resources and knowledge to work. Over the next 10 years, Sloan would award more than $44 million in grants in the field of biosecurity. Those grants changed the US strategic direction.

Author Gigi Kwik Gronvall, Senior Associate at the Center for Biosecurity of UPMC, chronicles Sloan's leadership in the field and the innovations that followed to show how the foundation helped lay the groundwork on which US civilian biosecurity has been built.

Who should read this? "Anyone who is interested in or works in biodefense and civilian preparedness," says Gronvall. "There is a lot of history in there, and people will learn why things are the way they are and also why preparedness is something that needs to be continually worked on over time."

"I hope other people will read this as a guidebook on how to effect real, positive change in government," she adds. "Because of Sloan's unique management style, and their commitment to try a range of ideas to see what would work, they provide a good tutorial for how to harness the passion, commitment, and energy of a diverse group of experts. And it worked. We have a way to go, but the US is much better prepared for a biological attack than it was in 2001."


'/>"/>

Contact: Molly D'Esopo
mdesopo@upmc-biosecurity.org
443-573-3307
Center for Biosecurity of UPMC
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Preparing for bioterrorism
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated ... interface solutions, today announced that its ClearPad ® ... (TDDI) products won two separate categories in the 8 ... Innovator and Best Technology Breakthrough. The Synaptics ® ... a simplified supply chain, thinner devices, brighter displays and ...
(Date:1/7/2016)... , Jan. 7, 2016 Various factors ... biopharmaceutical products such as biologics and biosimilars. Some ... reduce healthcare expenditure, growing demand for cost-effective alternatives, ... population. Biosimilars are similar versions of their corresponding ... to their quality, safety, and efficacy. The global ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/4/2016)... , February 4, 2016 Strasbourg, ... (ABL), Inc. --> Strasbourg, France , ... --> PharmaVentures is pleased to announce that it acted ... biopharmaceutical manufacturing unit in Strasbourg, France , ... --> --> Transgene (Euronext: TNG), ...
(Date:2/3/2016)... Feb. 3, 2016  Discovery Laboratories, Inc. (NASDAQ: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... approved an inducement award as a component of ... newly appointed President and Chief Executive Officer.  The ... on February 1, 2016 and granted as an ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
Breaking Biology Technology: